Equity Profile

GRDN

Guardian Pharmacy Services, Inc.

Health CareHealth Care Services$2.6B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be looking for continued growth.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and customer base, crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities. As the demand for specialized health care services continues to grow, Guardian's role in delivering tailored medication management is increasingly important.

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian reported an EPS of $0.29, surpassing expectations by 31.82%. However, the stock experienced a slight decline the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as Guardian has consistently beaten EPS estimates, but the lack of revenue guidance leaves uncertainty.

Bull Case

If Guardian continues its trend of beating EPS estimates, it could signal strong operational efficiency and market demand, potentially leading to a positive stock reaction.

Bear Case

On the other hand, the absence of revenue guidance raises concerns about future growth, which could lead to a negative market reaction if results fall short.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given Guardian's history of beating EPS estimates, this figure will be crucial in determining market sentiment.

What are the revenue expectations for the upcoming quarter?

Revenue guidance is essential for assessing the company's growth trajectory and ability to sustain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Guardian's ability to sustain its EPS growth despite the lack of revenue guidance, as historical performance shows a consistent ability to exceed expectations.

Supporting Evidence

Guardian has a 100% EPS beat rate over the last four quarters, indicating strong operational management.

Options pricing suggests a significant move, which may reflect investor confidence in the company's performance.

The stock has shown resilience in the face of uncertainty, with only slight declines following previous earnings beats.

Key Risk

If the EPS comes in below $0.25, it could challenge the narrative of sustained profitability.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing Guardian's ability to continue its trend of EPS beats against the uncertainty of revenue growth.

Bull Confirmed If

An EPS of $0.30 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.25 could indicate potential challenges in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±11.48%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Guardian beats expectations, history suggests the stock could rise by around 0.16% on the day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss on EPS could lead to a decline, with historical patterns suggesting a potential drop of around 1.48%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth strategies or new market opportunities.
2Details on cost management and operational efficiencies.
3Insights into customer retention rates and new client acquisitions.
4Management's outlook on the health care market and regulatory impacts.
5Any commentary on competitive positioning within the pharmacy services industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be looking for continued growth.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and customer base, crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian reported an EPS of $0.29, surpassing expectations by 31.82%. However, the stock experienced a slight decline the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as Guardian has consistently beaten EPS estimates, but the lack of revenue guidance leaves uncertainty.

Bull Case

If Guardian continues its trend of beating EPS estimates, it could signal strong operational efficiency and market demand, potentially leading to a positive stock reaction.

Bear Case

On the other hand, the absence of revenue guidance raises concerns about future growth, which could lead to a negative market reaction if results fall short.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given Guardian's history of beating EPS estimates, this figure will be crucial in determining market sentiment.

What are the revenue expectations for the upcoming quarter?

Revenue guidance is essential for assessing the company's growth trajectory and ability to sustain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Guardian's ability to sustain its EPS growth despite the lack of revenue guidance, as historical performance shows a consistent ability to exceed expectations.

Supporting Evidence

Guardian has a 100% EPS beat rate over the last four quarters, indicating strong operational management.

Options pricing suggests a significant move, which may reflect investor confidence in the company's performance.

The stock has shown resilience in the face of uncertainty, with only slight declines following previous earnings beats.

Key Risk

If the EPS comes in below $0.25, it could challenge the narrative of sustained profitability.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing Guardian's ability to continue its trend of EPS beats against the uncertainty of revenue growth.

Bull Confirmed If

An EPS of $0.30 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.25 could indicate potential challenges in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±11.48%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Guardian beats expectations, history suggests the stock could rise by around 0.16% on the day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss on EPS could lead to a decline, with historical patterns suggesting a potential drop of around 1.48%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth strategies or new market opportunities.
2Details on cost management and operational efficiencies.
3Insights into customer retention rates and new client acquisitions.
4Management's outlook on the health care market and regulatory impacts.
5Any commentary on competitive positioning within the pharmacy services industry.